Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines

Veterinary Quarterly

Volumn 22, Issue 4, 2000, Pages 223-227

  Maas, P A ^a   de Winter, M P M ^a   Venema, S ^a   Oei, H L ^a   Claassen, I J T M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; INACTIVATED VACCINE; VIRUS ANTIGEN; VIRUS FUSION PROTEIN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; BIRD DISEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GERMFREE ANIMAL; IMMUNOLOGY; INFECTIOUS BURSAL DISEASE VIRUS; METHODOLOGY; NEWCASTLE DISEASE PARAMYXOVIRUS; POULTRY; SENSITIVITY AND SPECIFICITY; STANDARD; TIME; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HN PROTEIN; INFECTIOUS BRONCHITIS VIRUS; INFECTIOUS BURSAL DISEASE VIRUS; NEWCASTLE DISEASE VIRUS; POULTRY; POULTRY DISEASES; SENSITIVITY AND SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; TIME FACTORS; VACCINES, INACTIVATED; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 0034305488     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2000.9695063     Document Type: Article

References (24)

1. Burkhardt F. Gluck R. Finkcl-Jimcncz H. and Brantscl cn S. I cpat.tts A-vaccincs: a comparison between three methods of antigen determination. Dev Biol Stand 1996; 86: 129-35.
2. Edcvig G and Granslrom M. The development and standardization ot an antigen detection ELISA for rubella virus grown in rabbit cells. J Biol Stand 1986; 14: 111-9.
3. European Pharmacopoeia, Third Edition. Published by the European Department for the Quality of Medicines within the Council of Europe, Strasbourg, Trance. 1997.
4. Fahey KJ, Emv KM, and Crooks J. A conformational immunogen on VP2 of infectious bursal disease vims that induces virus-neutrahzing antibodies that passively protect chickens. J Gen Virol 1J8 J; 32: 593
5. Gamoh K, Senda M, Itoh O. Muramatsu M, Flirayama N, Koike R, Endoh YS, and Minamoto N. Use of ELISA for in vitro potency test of Rabies vaccines for animal use. Biologicals 1996; 24:95-101.
6. Goddard RD, Nicholas RAJ, and Luff PR. Serology-based potency test for inactivated Newcastle disease vaccines. Vaccine 1988:6: 530-2.
7. Heinz F-X, Tuma W, Guirakhoo F, and Kunz C. A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of Tick-bome encephalitis vims. J Biol Stand 1986; 14: 133-41.
8. Henderson LM, Scheevel KF, and Walden DM. Development of an enzyme-linked immunosorbent assay for potency testing of Erysipelas bactcrins. Dev Biol Stand 1996; 86:333.
9. Horvath E, Czifra G, Nagy E, Engstrom B, and Merza M. Potency test of inactivated Newcastle disease vaccines by monoclonal antibody blocking ELISA. Vaccine 1999; 17:2969-73.
10. Iorio RM, Syddall RJ, Sheehan JP, Bratt MA, Glickman RL, and Riel AM. Neutralization map of the hcmagglutinin-neuraminidase glyco-protein of Newcastle disease vims: domains recognized by monoclonal antibodies that prevent receptor recognition. J Virol 1991; 65: 4999-5006.
11. Levings RL. Henderson LM, and Metz CA. In vitro potency assays for nonrcplicating veterinary vaccines: comparison to in vivo assays and considerations in assay development. Vet Microbiol 1993; 37:201-19.
12. U.S. Code of Federal Regulations; 113.8: In vitro tests for serial release. Published by the National Archives and Records Administration Office 1999.
13. Ludemann LR. and Katz JB. Assessment of inactivated bovine viral diarrhea vaccines using polyclonal or monoclonal antibodies in an ELISA procedure. 1992, Abst. P71,73rd Conf. Res. Workers in Anim Dis.
14. Maanen C van, and Terpstra C. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich F.LISA using monoclonal antibodies. Biologicals 1990; 18:315-9.
15. Maas RA, Oei HL, Venema-Kemper S, Koch G, and Bongers J. Dose response effects of inactivated Newcastle disease vaccines: influence of serological assay, time after vaccination and type of chickens. Avian Dis 1999; 43:670-7.
16. Nicstcrs HG. Blcumink-Pluym NM. Ostcrhaus AD, Horzinck MC, and Zcijst BA van der. Epitopes on the pcplomcr protein of infectious bronchitis vims strain M41 as defined by monoclonal antibodies. Virol 1987; 161:511-9.
17. Perrin P, Morgcaux S, and Sureau P. In vitro Rabies vaccine potency appraisal by ELISA: advantages of the immunocapturc method with a neutralizing anti-glycoprotein monoclonal antibody. Biologicals 1990;18:321-30.
18. Ruby KW, Cardclla MA, and Knudtson WU. Assay for measuring relative potency of leptospiral bactcrins containing serovar pontona. Biologicals 1992; 20:259-66.
19. Singer C. Knaucrt F, Bushar G, Klutch M, Lundquist R. and Quinnan JrGV. Quantitation of poliovims antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera monoclonal antibodies. J Biol Stand 1989; 17: 137-50.
20. Snyder DB, Lana DP, Clio BR. and Marquardt WW. Group and strain-specific neutralisation sites of IBDV defined with monoclonal anti-bodies. Avian Dis 1988; 32: 527-34.
21. Ummo Y, Kohama T, Sato TA. and Sugiura A. Protective effect of monoclonal antibodies to Newcastle disease vims in passive immunization. J Gen Virol 1990; 71: 1199-203.
22. Waterson JG, Pennington TH, and Allan WL I. Vimlcnce in Newcastle disease vims. A preliminary study. Brit Med Bull 1967; 23: 138-43.
23. Wilbur L. Statistical methods for analysis of in vitro antigen quantification data for veterinary biologic products. Vet Microbiol 1993; 37: 231-40.
24. Yusoff K, Nesbit M, McCartney H, Mculcmans G, Alexander DJ, Collins MS, Etnmerson PT, and Sanison ACR. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol 1989; 70:3105-9.